FROM THE TABLE OF CONTENTS
SOCIAL AND PARA-MEDICAL ASPECTS OF HALLUCINOGENIC DRUGS,
William H. McGlothlin, Ph.D.,
Research Associate, Department
of Psychology, University of Southern California
DOLPHIN-HUMAN RELATION AND LSD 25, John C. Lilly, M.D.,
Director, Communication Research Institute, Miami; St.
Thomas, V.I.
THEORETICAL ASPECTS OF LSD THERAPY, Dr. John Buckman,
M.R.C.S., L.R.C.P., D.P.M.,
Senior Hospital Medical Officer,
Marlborough Day Hospital, London
THE USE OF LSD 25 IN PERSONALITY DIAGNOSTICS AND THERAPY
OF PSYCHOGENIC DISORDERS, Stanislaw Grof, M.D.,
Research
Psychiatrist, Psychiatric Research Institute, Prague
LSD FACILITATION OF PSYCHOANALYTIC TREATMENT: A CASE
STUDY IN DEPTH, Charles Clay Dahlberg, M.D.,
Training and
Supervisory Analyst, William Alanson White Psychoanalytic In-
stitute, New York City
A CASE OF CHANGE AND PARTIAL REGRESSION FOLLOWING ONE
LSD 25 TREATMENT, Jack L. Ward, M.D.,
Staff Psychiatrist, New
Jersey Reformatory at Bordentown, Mercer Hospital
A PROGRAM FOR THE TREATMENT OF ALCOHOLISM: LSD, MAL-
VARIA AND NICOTINIC ACID, Abram Hoffer, M.D.,
Director, Psy-
chiatric Research, Department of Public Health, Saskatchewan
A COMMENT ON SOME USES OF PSYCHOTOMIMETICS IN PSYCHI-
ATRY, Humphry Osmond, M.R.C.S., L.R.C.P., D.P.M., F.W.A.,
Director, Bureau of Neurology and Psychiatry, New Jersey
Neuropsychiatric Institute
IS LSD OF VALUE IN TREATING ALCOHOLICS?, Ruth Fox, M.D.,
Medical Director, National Council on
Alcoholism
PSYCHOTHERAPY WITH LSD, Sidney Cohen, M.D.,
Chief, Psycho
somatic Medicine, Veterans Administration Hospital, Los
Angeles
PRELIMINARY METHOD FOR STUDY OF LSD WITH CHILDREN,
Andre Rob, M.D.,
Director,
Leonard W. Krinsky, Ph.D.,
Direc-
tor, Psychological Service,
Harold A. Abramson, M.D.,
Director
of Research,
L. Goldfarb, M.D.,
Clinical Director, South Oaks Psychiatric Hospital, Amityville, New York